Chemical Stability of Ceftolozane/Tazobactam in Polyvinylchloride Bags and Elastomeric Pumps

por Terracciano, Joseph, Rhee, Elizabeth G., Walsh, Jacqueline
Publicado 2017

2227. Outcomes in Patients with Renal Impairment from a Phase 3 Clinical Trial for Ceftolozane–Tazobactam (C/T) Treatment of Nosocomial Pneumonia (ASPECT-NP)

por Huntington, Jennifer A, Yu, Brian, Li, Linping, Jensen, Erin, Bruno, Christopher, Rhee, Elizabeth G
Publicado 2019

624. Molecular Characterization of Baseline Enterobacteriaceae and Pseudomonas aeruginosa from a Phase 3 Nosocomial Pneumonia (ASPECT-NP) Clinical Trial

por Castanheira, Mariana, Johnson, Matthew G, Yu, Brian, Huntington, Jennifer A, Carmelitano, Patricia, Bruno, Christopher, Rhee, Elizabeth G, Motyl, Mary
Publicado 2019

Probability of Target Attainment Analyses to Inform Ceftolozane/Tazobactam Dosing Regimens for Patients With Hospital‐Acquired or Ventilator‐Associated Bacterial Pneumonia and End‐...

por Feng, Hwa‐Ping, Patel, Yogesh T., Zhang, Zufei, Fiedler‐Kelly, Jill, Bruno, Christopher J., Rhee, Elizabeth G., De Anda, Carisa, Gao, Wei
Publicado 2022

Exposure–Efficacy Analyses Support Optimal Dosing Regimens of Ceftolozane/Tazobactam in Participants with Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia in ASPECT-NP

por Gao, Wei, Passarell, Julie, Patel, Yogesh T., Zhang, Zufei, Lin, Gina, Fiedler-Kelly, Jill, Bruno, Christopher J., Rhee, Elizabeth G., De Anda, Carisa S., Feng, Hwa-Ping
Publicado 2022

Lung penetration, bronchopulmonary pharmacokinetic/pharmacodynamic profile and safety of 3 g of ceftolozane/tazobactam administered to ventilated, critically ill patients with pneu...

por Caro, Luzelena, Nicolau, David P, De Waele, Jan J, Kuti, Joseph L, Larson, Kajal B, Gadzicki, Elaine, Yu, Brian, Zeng, Zhen, Adedoyin, Adedayo, Rhee, Elizabeth G
Publicado 2020

Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects

por Rizk, Matthew L., Rhee, Elizabeth G., Jumes, Patricia A., Gotfried, Mark H., Zhao, Tian, Mangin, Eric, Bi, Sheng, Chavez-Eng, Cynthia M., Zhang, Zufei, Butterton, Joan R.
Publicado 2018

2226. Impact of Prior and Concomitant Antibacterial Therapy on Outcomes in the ASPECT-NP Randomized, Controlled Trial of Ceftolozane/Tazobactam (C/T) vs. Meropenem (MEM) in Patient...

por Wunderink, Richard G, Bruno, Christopher, Martin-Loeches, Ignacio, Kollef, Marin, Timsit, Jean-Francois, Yu, Brian, Huntington, Jennifer A, Li, Linping, Jensen, Erin, Wolf, Dominik, Butterton, Joan R, Rhee, Elizabeth G
Publicado 2019

1143. Safety and Efficacy of Ceftolozane/Tazobactam Versus Meropenem in Neonatal and Pediatric Participants With Complicated Urinary Tract Infection, Including Pyelonephritis: A Ph...

por Roilides, Emmanuel, Ashouri, Negar, Bradley, John S, Johnson, Matthew G, Lonchar, Julia, Su, Feng-Hsiu, Huntington, Jennifer A, Popejoy, Myra W, Bensaci, Mekki, De Anda, Carisa S, Rhee, Elizabeth G, Bruno, Christopher
Publicado 2021

Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants

por Rhee, Elizabeth G., Rizk, Matthew L., Calder, Nicole, Nefliu, Marcela, Warrington, Steven J., Schwartz, Michael S., Mangin, Eric, Boundy, Keith, Bhagunde, Pratik, Colon-Gonzalez, Francheska, Jumes, Patricia, Liu, Yang, Butterton, Joan R.
Publicado 2018

Ceftolozane/tazobactam probability of target attainment and outcomes in participants with augmented renal clearance from the randomized phase 3 ASPECT-NP trial

por Shorr, Andrew F., Bruno, Christopher J., Zhang, Zufei, Jensen, Erin, Gao, Wei, Feng, Hwa-Ping, Huntington, Jennifer A., Yu, Brian, Rhee, Elizabeth G., De Anda, Carisa, Basu, Sumit, Kollef, Marin H.
Publicado 2021

Safety and Efficacy of Ceftolozane/Tazobactam Versus Meropenem in Neonates and Children With Complicated Urinary Tract Infection, Including Pyelonephritis: A Phase 2, Randomized Cl...

por Roilides, Emmanuel, Ashouri, Negar, Bradley, John S., Johnson, Matthew G., Lonchar, Julia, Su, Feng-Hsiu, Huntington, Jennifer A., Popejoy, Myra W., Bensaci, Mekki, De Anda, Carisa, Rhee, Elizabeth G., Bruno, Christopher J.
Publicado 2023

1154. Safety and Efficacy of Ceftolozane/Tazobactam Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-abdominal Infection: A Phase 2, Randomized...

por Jackson, Carl-Christian A, Newland, Jason, Dementieva, Natalia, Lonchar, Julia, Su, Feng-Hsiu, Huntington, Jennifer A, Bensaci, Mekki, Popejoy, Myra W, Johnson, Matthew G, De Anda, Carisa S, Rhee, Elizabeth G, Bruno, Christopher
Publicado 2021

Safety and Efficacy of Ceftolozane/Tazobactam Plus Metronidazole Versus Meropenem From a Phase 2, Randomized Clinical Trial in Pediatric Participants With Complicated Intra-abdomin...

por Jackson, Carl-Christian A., Newland, Jason, Dementieva, Nataliia, Lonchar, Julia, Su, Feng-Hsiu, Huntington, Jennifer A., Bensaci, Mekki, Popejoy, Myra W., Johnson, Matthew G., De Anda, Carisa, Rhee, Elizabeth G., Bruno, Christopher J.
Publicado 2023

Vaccination with Heat-killed Leishmania Antigen or Recombinant Leishmanial Protein and CpG Oligodeoxynucleotides Induces Long-Term Memory CD4(+)and CD8(+)T Cell Responses and Prote...

por Rhee, Elizabeth G., Mendez, Susana, Shah, Javeed A., Wu, Chang-you, Kirman, Joanna R., Turon, Tara N., Davey, Dylan F., Davis, Heather, Klinman, Dennis M., Coler, Rhea N., Sacks, David L., Seder, Robert A.
Publicado 2002

Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial

por Timsit, Jean-François, Huntington, Jennifer A., Wunderink, Richard G., Shime, Nobuaki, Kollef, Marin H., Kivistik, Ülo, Nováček, Martin, Réa-Neto, Álvaro, Martin-Loeches, Ignacio, Yu, Brian, Jensen, Erin H., Butterton, Joan R., Wolf, Dominik J., Rhee, Elizabeth G., Bruno, Christopher J.
Publicado 2021